Victory Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,866
Closed -$309K 2703
2022
Q2
$309K Buy
13,866
+622
+5% +$13.9K ﹤0.01% 2225
2022
Q1
$285K Buy
13,244
+3,805
+40% +$81.9K ﹤0.01% 2315
2021
Q4
$338K Sell
9,439
-159
-2% -$5.69K ﹤0.01% 2340
2021
Q3
$408K Sell
9,598
-1,183
-11% -$50.3K ﹤0.01% 2276
2021
Q2
$467K Sell
10,781
-2,851
-21% -$123K ﹤0.01% 2238
2021
Q1
$556K Sell
13,632
-226
-2% -$9.22K ﹤0.01% 2154
2020
Q4
$627K Buy
13,858
+206
+2% +$9.32K ﹤0.01% 1963
2020
Q3
$483K Buy
13,652
+2,832
+26% +$100K ﹤0.01% 1972
2020
Q2
$408K Sell
10,820
-15,334
-59% -$578K ﹤0.01% 2053
2020
Q1
$756K Buy
26,154
+15,389
+143% +$445K ﹤0.01% 1946
2019
Q4
$558K Buy
10,765
+6,213
+136% +$322K ﹤0.01% 1958
2019
Q3
$250K Buy
+4,552
New +$250K ﹤0.01% 2140
2018
Q3
Sell
-5,826
Closed -$186K 1792
2018
Q2
$186K Buy
5,826
+798
+16% +$25.5K ﹤0.01% 1634
2018
Q1
$250K Buy
5,028
+1,009
+25% +$50.2K ﹤0.01% 1539
2017
Q4
$217K Buy
4,019
+348
+9% +$18.8K ﹤0.01% 1534
2017
Q3
$213K Sell
3,671
-389
-10% -$22.6K ﹤0.01% 1496
2017
Q2
$200K Buy
4,060
+608
+18% +$30K ﹤0.01% 1446
2017
Q1
$150K Buy
3,452
+1,402
+68% +$60.9K ﹤0.01% 1503
2016
Q4
$100K Sell
2,050
-51
-2% -$2.49K ﹤0.01% 1553
2016
Q3
$101K Buy
2,101
+543
+35% +$26.1K ﹤0.01% 1523
2016
Q2
$84K Buy
1,558
+679
+77% +$36.6K ﹤0.01% 1359
2016
Q1
$39K Buy
+879
New +$39K ﹤0.01% 1493
2015
Q3
Sell
-1,411
Closed -$47K 1626
2015
Q2
$47K Buy
+1,411
New +$47K ﹤0.01% 1506